Review: biofeedback seems effective for pediatric migraine

Review: biofeedback seems effective for pediatric migraine

(HealthDay)—For pediatric patients with migraine, biofeedback seems to be an effective intervention, according to a review published online July 26 in Pediatrics.

Anker Stubberud, from the NTNU Norwegian University of Science and Technology in Trondheim, and colleagues examined the pooled evidence for the effectiveness of for childhood migraine. Data were included from five prospective, randomized controlled trials of biofeedback with a total of 137 participants.

The researchers found that, compared with a waiting-list control, biofeedback reduced the frequency of migraine (mean difference, −1.97), duration of attack (mean difference, −3.94), and headache intensity (mean difference, −1.77) (all P < 0.00001). When combined with other , biofeedback demonstrated no adjuvant effect; there was also no significant advantage for biofeedback over active treatment. Forty percent of bias judgments were considered to be low risk.

"Biofeedback seems to be an effective intervention for pediatric migraine, but in light of the limitations, further investigation is needed to increase our confidence in the estimate," the authors write.

More information: Full Text (subscription or payment may be required)

Journal information: Pediatrics

Copyright © 2016 HealthDay. All rights reserved.

Citation: Review: biofeedback seems effective for pediatric migraine (2016, July 28) retrieved 23 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Prevalence of migraine up in patients with cardiac syndrome X


Feedback to editors